Tirzepatide

Synthetic dual GIP/GLP-1 receptor agonist peptide.

Product summary for procurement. The specification, Safety Data Sheet and batch Certificate of Analysis are supplied as separate documents. Not medical advice.

1. Identity

Product name	Tirzepatide
Synonyms	Tirzepatide (INN), LY3298176, GIP/GLP-1 dual agonist peptide
CAS number	2023788-19-2
Molecular formula	C225H348N48O68
Molecular weight	4813.45 g/mol (reference literature value)
Product type	Synthetic peptide (dual GIP/GLP-1 receptor agonist analogue)
Category	Peptides & Peptide Materials
Identity testing	Confirmed for every batch on the Certificate of Analysis

Tirzepatide is a synthetic 39-amino-acid peptide described in public reference sources as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, incorporating non-natural amino acid residues and a C20 fatty diacid moiety associated with prolonged circulation. In many jurisdictions tirzepatide is a prescription pharmaceutical substance and supply is restricted to authorised entities. This record documents chemical identity only. No purity claim, impurity profile, peptide content, sterility, endotoxin result, or documentation set is asserted; those attributes are batch-specific and require a Certificate of Analysis issued against an agreed specification.

2. Quality and handling

Purity	≥99.0% (HPLC)
Physical form	Stated on the Certificate of Analysis.
Storage	Stated on the Safety Data Sheet and Certificate of Analysis supplied with each batch.
Packaging	Sealed, labelled containers suited to the order quantity; confirmed on your quotation.

3. Test parameters

Appearance (Visual)	Conforms
Solubility (Visual (stated solvent and concentration))	Conforms
Identity (molecular mass) (ESI-MS)	Conforms
Purity (RP-HPLC (area %))	≥ 99.0 %
Largest single impurity (RP-HPLC (area %))	Per specification
Peptide content (Nitrogen analysis or amino acid analysis)	Per specification
Water content (Karl Fischer)	Per specification
Counter-ion (acetate / TFA) (Ion chromatography or HPLC)	Per specification
Residual solvents (GC headspace (ICH Q3C))	Conforms: Meets ICH Q3C limits
Bacterial endotoxins (LAL (Ph. Eur. 2.6.14 / USP <85>))	Per specification
Amino acid analysis (AAA after hydrolysis)	Report result

Batch results are reported on the Certificate of Analysis supplied with each order.

4. Regulatory information

Classification	Supplied with buyer declaration
Status notes	Prescription / Jurisdiction Dependent
Enquiry handling	Online quote; buyer declaration checked at payment

5. Documentation

Product specification	Prepared for you and released to your private enquiry page on request
Certificate of Analysis (COA)	Issued for your batch and shipped with the order
Safety Data Sheet (SDS)	Prepared for you and released to your private enquiry page on request
Analytical data (chromatograms / spectra)	Prepared for you and released to your private enquiry page on request
End-use / end-user declaration	Prepared for you and released to your private enquiry page on request